Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

FARE announces recipients of 2017 Investigator in Food Allergy Awards

FARE announces recipients of 2017 Investigator in Food Allergy Awards

Researchers find increase in prescription of epipens for children with allergies

Researchers find increase in prescription of epipens for children with allergies

Bees pose biggest public health threat in Australia, research shows

Bees pose biggest public health threat in Australia, research shows

Plans for schools to hold spare adrenaline auto-injector continue to progress positively

Plans for schools to hold spare adrenaline auto-injector continue to progress positively

New US guidelines developed for the prevention of peanut allergy

New US guidelines developed for the prevention of peanut allergy

New study shows efficacy of Ebola vaccine in offering protection against disease

New study shows efficacy of Ebola vaccine in offering protection against disease

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Experimental Ebola vaccine offers high protection against deadly virus, reveals major trial

Leading nonprofit patient education organization offers allergy-related restaurant safety tips

Leading nonprofit patient education organization offers allergy-related restaurant safety tips

Experts characterize racial and ethnic differences in food allergies among U.S. children

Experts characterize racial and ethnic differences in food allergies among U.S. children

New technique shows promise for therapeutic reversal of food allergies

New technique shows promise for therapeutic reversal of food allergies

Researchers discover new therapeutic target for controlling fatal allergic reactions

Researchers discover new therapeutic target for controlling fatal allergic reactions

New bio-photonic device aims to take drug hypersensitivity detection into new era

New bio-photonic device aims to take drug hypersensitivity detection into new era

FAAM 2016: Experts discuss advancements in diagnosis, management of food allergies and anaphylaxis

FAAM 2016: Experts discuss advancements in diagnosis, management of food allergies and anaphylaxis

Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin allergy testing: an interview with Dr. Eric Macy

Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

Study finds oral immunotherapy safe, effective at suppressing peanut allergy in preschool children

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

FDA approves new injection to improve blood sugar levels in adults with type 2 diabetes

Researchers aim to improve medical treatment for people with insect venom allergy

Researchers aim to improve medical treatment for people with insect venom allergy

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Zinbryta gets FDA approval for treating adults with relapsing forms of MS

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk

Food-triggered atopic dermatitis in children may lead to life-threatening anaphylaxis risk